My Companies
Notification
Account
Log Out
Back

Caplin Point Gains INVIMA GMP Compliance Confirmation For Oncology Manufacturing Unit


1 September 2026
Caplin Point Laboratories Ltd.

Caplin One Labs received INVIMA confirmation of GMP compliance for manufacturing oncology products, covering sterile lyophilized injectable powders and non-sterile tablets and hard capsules. The formal certificate is expected separately.


Recent Events

Real time WhatsApp alerts using AI.

Get features of

  • Instant Notifications
  • Competitive Advantage
  • Critical Alerts
Signup or Sign in

Company Information